Promega Nanobi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Promega Corporation: SARS-CoV-2 Antibody Test Developed by Promega Receives CE Mark
Novel bioluminescent Lumit Dx SARS-CoV-2 Immunoassay enables simple, scalable antibody detection
A SARS-CoV-2 antibody test developed by Promega Corporation, the Lumit Dx SARS-CoV-2 Immunoassay, has received CE marking and is now available in Europe. The novel bioluminescent immunoassay is a qualitative in vitro diagnostic test intended to detect antibodies to SARS-CoV-2 in serum.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210609005062/en/
The Lumit Dx SARS-CoV-2 Immunoassay by Promega has received CE marking. The novel bioluminescent immunoassay is a qualitative in vitro diagnostic test intended to detect antibodies to SARS-CoV-2 in serum. (Photo: Business Wire) ....

United States , Ashley Anderson , Kostenloser Wertpapierhandel , Promega Nanobi , Us Centers For Disease Control , European Laboratory Research , Drug Administration , Innovation Group , Promega Corporation , Corporate Affairs , Business Wire , Promega Chief Medical Officer Ashley Anderson , Disease Control , Multiplex Assay , Total Nucleic Acid Purification Kit , Novel Coronavirus Real Time , Xpressamp Direct Amplification Reagents , ஒன்றுபட்டது மாநிலங்களில் , ஆஷ்லே ஆண்டர்சன் , எங்களுக்கு மையங்கள் க்கு நோய் கட்டுப்பாடு , ஐரோப்பிய ஆய்வகம் ஆராய்ச்சி , கண்டுபிடிப்பு குழு , ப்ரொமெகா நிறுவனம் , பெருநிறுவன வாழ்க்கைத்தொழில்கள் , வணிக கம்பி , நோய் கட்டுப்பாடு ,